WAM
DPLO

Wealthspire Advisors (Maryland)’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,271
Closed -$17K – 2648
2018
Q4 		$17K Buy
1,271
+210
+20% +$3.54K ﹤0.01% 1286
2018
Q3 		$21K Buy
1,061
+207
+24% +$4.41K ﹤0.01% 1297
2018
Q2 		$22K Sell
854
-882
-51% -$20.6K ﹤0.01% 1291
2018
Q1 		$35K Buy
1,736
+206
+13% +$4.81K ﹤0.01% 1119
2017
Q4 		$31K Buy
1,530
+1,518
+12,650% +$29.9K ﹤0.01% 1184
2017
Q3 		$0 Buy
12
+5
+71% +$85 ﹤0.01% 2562
2017
Q2 		$0 Hold
7
– – ﹤0.01% 2332
2017
Q1 		$0 Hold
7
– – ﹤0.01% 2069
2016
Q4 		$0 Buy
+7
New +$130 ﹤0.01% 1893

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s DPLO Position: Q1 2019 in Review

Wealthspire Advisors (Maryland) sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 1,271 shares — an estimated $17K sold.

Wealthspire Advisors (Maryland) first reported a position in DPLO in Q4 2016 and held it in 9 quarters. The position peaked at $35K in Q1 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • Wealthspire Advisors (Maryland) reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 1,271 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $17K.
  • Wealthspire Advisors (Maryland) first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 9 quarters.
  • Wealthspire Advisors (Maryland)'s DIPLOMAT PHARMACY, INC. position peaked at $35K in Q1 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2019, filed 13 May 2019.